Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600126666Phase 4Not yet recruiting
Phase 4 trial of anlatrelvir and baloxavir marboxil in Influenza A infection (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Time to alleviation of influenza symptoms (TTAS). Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600126666.